EventsThe 4th International Electronic Conference on Nutrients
Published
This submission belongs to the session S4. Global Nutrition Trends: Shaping Health and Athletic Performance of the event The 4th International Electronic Conference on Nutrients
Published date
11 Oct, 2024
Academic Editor
author-avatarMauro Lombardo
Citation
Diego Fernández Lázaro, Álvaro López Llorente, Ana María Celorrio San Miguel, Gema Santamaría Gómez, Carlos Domínguez Ortega, Enrique Roche, Comparative efficiency of EPO-Boost Natural Blood Builder and Blood Booster Active 17 supplementation on hematological biomarkers and athletic performance in CrossFit® athletes: A randomized placebo-controlled trial., in Proceedings of The 4th International Electronic Conference on Nutrients, 16 October–18 October 2024, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Comparative efficiency of EPO-Boost Natural Blood Builder and Blood Booster Active 17 supplementation on hematological biomarkers and athletic performance in CrossFit® athletes: A randomized placebo-controlled trial.

image
Carlos Domínguez Ortega 5
image
1. Histology Area and Neurobiology Research Group, Faculty of Medicine, University of Valladolid, 47005, Valladolid, Spain, Spain
2. Faculty of Health Sciences, University of Valladolid, Campus de Soria, 42003 Soria, Spain., Spain
3. Doctoral School University of León, University of Leon, Campus de Vegazana, 24071 Leon, Spain, Spain
4. Department of Anatomy and Radiology, Faculty of Health Sciences, Campus de Soria, University of Valladolid, 42003 Soria, Spain, Spain
5. University Hospital of Burgos, Av. Islas Baleares, 3, 09006 Burgos, Spain, Spain
6. Alicante Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain, Spain
7. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain
Abstract

Introduction: Iron is essential in athletes’ performance, as it is essential in cellular respiration and metabolism. However, the increased demand for iron due to strenuous and demanding exercise, along with dietary iron insufficiencies, amplifies the risk of iron deficiency and possibly anemia.

Methods: Our study aimed to evaluate the comparative efficacy of oral supplementation with EPO-Boost Natural Blood Builder (EB) and Blood Booster Active 17 (BB) after 10 weeks of programmed training in 32 male CrossFit® athletes (26.0 ± 5.7 years; 180.3 ± 7.9 cm; 23.9 ± 1.7 kg/m2). Participants were randomized into three groups and received EB, BB, or a placebo (control group: CG), with the same structured training and diet, in a single-blind, placebo-controlled, randomized trial.

Results: Statistically significant differences were found only in serum ferritin (FER) levels (p = 0.015; η²p = 0.326). The CG experienced a 14.33% decrease, the EB group displayed a 3.60% increase, and the BB group showed a 20.22% increase. Although no statistically significant changes were detected in serum iron levels (sFe) (p = 0,383; η²p = 0,032), it is noteworthy that there was a 10.58% decrease in the CG and a 23.76% increase in the BB group. Significant differences were found in iron storage levels in the CG (p = 0,031) throughout the study. In this regard, three CrossFit® athletes who were categorized with adequate iron levels at the beginning of the intervention shifted to a state of functional iron deficiency at the end of the study. Regarding athletic performance, no statistically significant differences were observed in aerobic (p = 0.483; η²p = 0.072) or anaerobic (p = 0,.83; η²p = 0,035) thresholds between the CG, EB, and BB.

Conclusion: Supplementation with EB and BB improves FER levels and could help prevent iron deficiency, although this does not translate into increased athletic performance.

Keywords
CrossFit®
exercise
iron
sports anemia
sports supplementation.
Poster
sciforum-100765-Diego Lazaro.pdf
FORMULATION AND EVALUATION OF A PROBIOTIC DRAGON FRUIT (HYLOCERUS UNDATUS)– HONEY BEVERAGE
Impact of catechin supplementation in older adults with sarcopenia on circulating biomarkers of health status: a systematic review of clinical trials.